Customizable nanomedicine platform shows promise for advancing personalized mRNA cancer therapeutics

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have limited progress.